
What Is Medical Device Cybersecurity?
Medical device cybersecurity is the ongoing process of monitoring, identifying, and addressing vulnerabilities in networked clinical equipment throughout its operational lifecycle. For hospitals, clinics, and specialty practices, that definition now covers a substantial share of the clinical environment: infusion pumps, imaging systems, patient monitors, ventilators, insulin pumps, and dozens of other connected devices that transmit patient data and, in many cases, control clinical functions directly.
These devices are collectively called the Internet of Medical Things (IoMT). The World Health Organization estimates there are more than 2 million distinct types of medical devices in use globally, and a growing share of them are networked. Unlike traditional IT assets, most were not designed with security as a primary engineering requirement. Many run proprietary firmware or legacy operating systems that cannot receive standard security patches. They remain on clinical networks for years, sometimes decades, long past the point when manufacturers provide software updates.
Attackers understand this gap well. Medical records sell for up to $1,000 each on dark web markets, far more than credit card data, which makes healthcare a financially attractive target regardless of organization size. The consequences extend well beyond data loss: a ransomware infection that locks imaging equipment forces diagnostic delays, while a compromised infusion pump can affect medication delivery directly. That intersection of patient safety and data security makes medical device cybersecurity a board-level concern, not just an IT department problem.
This guide covers the threat environment facing connected medical devices, the regulatory requirements from the FDA and HIPAA, and the practical steps your organization needs to build a defensible program. For a broader HIPAA foundation, see our HIPAA cybersecurity requirements guide.
Medical Device Security By The Numbers
Direct losses from the February 2024 ransomware attack, per UnitedHealth Group public reporting
Maximum dark web market price for healthcare records, compared to approximately $5 for stolen credit card data
Infusion pumps as a share of connected medical devices in a typical hospital environment (Forescout research)
The Threat Environment Facing Connected Medical Devices
Medical devices present a uniquely difficult security challenge because they sit at the intersection of operational technology (OT) and healthcare IT, two disciplines with different priorities, different patching cycles, and different risk tolerances. Security controls that work well for a managed workstation often cannot be applied to an infusion pump or an MRI controller without clinical validation and vendor approval.
Legacy Software and Unpatched Firmware
A significant share of networked medical devices still run Windows 7, Windows XP Embedded, or proprietary operating systems that no longer receive security updates. When a vulnerability is publicly disclosed, IT teams can patch a workstation within days. Patching a networked ventilator or a radiation therapy system is a fundamentally different process. It may require FDA clearance review, vendor-coordinated deployment, and downtime scheduling that stretches the patching window months into the future.
The MITRE ATT&CK for ICS framework documents the tactics adversaries use against industrial control and embedded systems, many of which apply directly to medical devices. Techniques such as "Exploit Public-Facing Application" (T0819) and "Supply Chain Compromise" (T0862) have been observed in healthcare-targeted attacks. According to Forescout research, routers connecting medical devices to clinical networks account for roughly half of the most severe vulnerabilities found in IoMT environments, making network access controls a first-priority defensive measure.
Ransomware: The Dominant Threat Vector
Ransomware groups target healthcare because organizations under pressure to restore clinical operations are more willing to pay. The February 2024 Change Healthcare attack disabled payment processing across hundreds of U.S. hospitals and clinics for weeks, resulting in approximately $874 million in direct losses according to UnitedHealth Group. When a threat actor gains initial access through a phishing email or an unpatched perimeter device, they pivot laterally across the network toward medical devices and building systems, assets that are harder to restore quickly and create maximum operational pressure.
The Verizon 2025 Data Breach Investigations Report identifies healthcare as one of the most frequently targeted sectors, with system intrusion and basic web application attacks accounting for the majority of confirmed incidents. Our guide to ransomware attacks covers the full attack chain and the mitigation strategies most relevant to clinical environments.
Supply Chain and Third-Party Risk
Medical device manufacturers, remote monitoring vendors, and biomedical engineering firms all require network access to service equipment. Each of those connections extends your attack surface. Trusted software update mechanisms that deliver firmware improvements can also be turned into attack vectors, a pattern documented in supply chain incidents affecting healthcare organizations. For a detailed look at how nation-state actors have exploited this vector, see our analysis of the Iran-backed wiper attack targeting Stryker MedTech in 2026.
FDA Cybersecurity Requirements Now Apply to All New Connected Devices
Section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in 2023, requires manufacturers of internet-connected "cyber devices" to submit a Software Bill of Materials (SBOM), maintain a coordinated vulnerability disclosure policy, and provide patches throughout the device's designed useful life. Healthcare organizations purchasing new connected equipment should verify that vendors comply with these requirements before signing procurement contracts.
Which Medical Devices Carry the Highest Risk?
Not all connected devices carry equal risk. Understanding which device categories present the greatest exposure helps security and biomedical teams allocate limited resources effectively.
Imaging systems including MRI machines, CT scanners, ultrasound units, and X-ray systems communicate via DICOM (Digital Imaging and Communications in Medicine) and connect to Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS). These devices frequently run legacy operating systems and hold large volumes of patient data. A compromise of a PACS server can expose thousands of patient imaging records simultaneously, and DICOM traffic traversing insufficiently segmented networks is readable without additional authentication.
Infusion pumps account for approximately 38% of the typical hospital's connected device footprint. Many support wireless communication for drug library updates, creating an attack surface if those update channels lack proper authentication. Unauthorized access to an infusion pump has direct patient safety implications. The FDA has issued safety communications on specific pump models with identified vulnerabilities.
Insulin pumps and implantable devices with wireless connectivity present a different risk profile: they operate outside hospital network perimeters and depend almost entirely on manufacturer security controls. Security researchers have demonstrated that certain older wireless-enabled insulin pump models could be manipulated by an attacker within radio range. While real-world exploitation of implantable devices remains rare, the FDA has issued safety communications on specific device models as vulnerabilities have been discovered.
Laboratory information systems and analyzers communicate using HL7 (Health Level Seven) messaging standards for result transmission. These systems often bridge clinical and administrative networks, making them a useful pivot point for attackers who have established an initial foothold.
Administrative medical devices including check-in kiosks, telehealth endpoints, and badge readers carry lower direct clinical risk but frequently receive less security attention, making them viable initial access points for lateral movement. Our healthcare data breach prevention guide covers how attackers move between device categories once initial access is established.
Bottom Line
Imaging systems and infusion pumps carry the highest combined risk because they run legacy software, hold ePHI at scale, and, in the case of infusion pumps, directly affect medication delivery. These two categories should be your first priority for network segmentation and compensating controls.
FDA and HIPAA Regulatory Requirements for Medical Device Security
Medical device cybersecurity operates under two overlapping regulatory frameworks: FDA guidance governing device manufacturers and HIPAA requirements governing covered entities and their business associates. Understanding which requirements apply to your organization is the foundation of any compliance effort.
FDA Section 524B Requirements
The FDA's authority over medical device cybersecurity expanded substantially with the passage of Section 524B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), enacted as part of the Consolidated Appropriations Act of 2023. Under this law, manufacturers of internet-connected "cyber devices" must submit a Software Bill of Materials (SBOM) identifying all commercial, open-source, and off-the-shelf software components; maintain a coordinated vulnerability disclosure policy that allows security researchers to report issues; monitor postmarket cybersecurity risks; and deploy patches or mitigations within a reasonably justified timeframe.
For healthcare delivery organizations, the practical implication is that you should now contractually require manufacturers to provide SBOMs, disclose vulnerabilities promptly, and deliver patches on defined timelines. Purchasing decisions should include an evaluation of the manufacturer's Security Development Lifecycle (SDL) practices before contracts are signed. NIST SP 800-82 Rev. 3 provides specific guidance on securing operational technology environments, including medical devices classified as OT assets, with a risk management framework that maps directly to the controls biomedical engineering and IT security teams need to implement together.
HIPAA Security Rule Applicability
The HIPAA Security Rule (45 CFR Part 164) requires covered entities to implement administrative, physical, and technical safeguards for electronic protected health information (ePHI). Medical devices that store, process, or transmit ePHI are fully in scope, which covers most networked clinical devices. Key provisions include access control (§164.312(a)), audit controls (§164.312(b)), integrity controls (§164.312(c)), and transmission security (§164.312(e)).
A thorough HIPAA security risk assessment must address your connected device inventory, not just workstations and servers. The HHS Office for Civil Rights (OCR) has cited inadequate device security controls in several enforcement actions, with penalties ranging from $65,000 to $4.3 million for covered entities that failed to implement proper safeguards for medical devices containing ePHI. Our guide on HIPAA compliance for dental offices illustrates how these obligations apply even in smaller clinical settings.
Building a Medical Device Cybersecurity Program: Five Core Steps
Build a Complete Device Inventory
Document every networked medical device, including device type, manufacturer, OS version, firmware version, network location, and ePHI handling status. You cannot protect what you cannot see. Include devices that biomedical engineering teams manage separately from the main IT asset inventory.
Segment Devices by Risk Tier
Place medical devices in dedicated network zones separated from corporate workstations, guest Wi-Fi, and administrative systems. Tier 1 (infusion pumps, ventilators) gets maximum isolation with deny-all-inbound defaults. Tier 2 (imaging systems) restricts communication to PACS, RIS, and monitored vendor channels. Tier 3 (administrative devices) stays isolated from clinical device zones.
Control Vendor and Third-Party Access
Replace persistent vendor VPN credentials with just-in-time, session-scoped access that requires approval, is limited to the specific devices being serviced, and generates a full audit log. Require SBOMs and Business Associate Agreements (BAAs) from all vendors with access to devices handling ePHI.
Implement Continuous Network Monitoring
Deploy network-based monitoring that observes device communication behavior without requiring agents on the devices themselves. Set baselines for normal communication patterns and alert on deviations. Managed Detection and Response (MDR) services can fill this role cost-effectively for organizations without a dedicated security operations team.
Develop Device-Specific Incident Response Playbooks
Create playbooks for each device category that identify who has clinical authority to approve isolation decisions, what manual or alternate-device workarounds exist, and how long those workarounds can be safely maintained. Validate the plan through tabletop exercises before you need it in a real incident.
Medical Device Security Implementation Checklist
- Build a complete inventory of all networked medical devices, including device type, OS version, firmware version, and network location
- Identify all devices running end-of-life operating systems such as Windows XP, Windows 7, or unsupported embedded OS versions
- Segment medical devices into dedicated network zones with deny-all-inbound default firewall policies
- Implement allow-list firewall rules that restrict each device to communication with only required management systems
- Require SBOMs and coordinated vulnerability disclosure policies from manufacturers before purchasing new connected devices
- Replace persistent vendor VPN credentials with just-in-time, session-scoped access provisioning
- Confirm that all vendors with access to devices containing ePHI have signed Business Associate Agreements
- Include the connected device inventory and known vulnerabilities in your annual HIPAA security risk assessment
- Develop device-specific incident response playbooks that identify clinical authority for isolation decisions and manual workarounds
- Validate segmentation controls through annual penetration testing and quarterly firewall rule reviews
Managing Vendor and Third-Party Access to Medical Devices
Every vendor that connects to your medical device network, whether for remote diagnostics, software updates, or biomedical maintenance, extends your attack surface. Third-party access is one of the most frequent entry points in healthcare breaches, and medical device vendors are often granted broad, persistent access that receives inadequate oversight.
Pre-purchase security assessments should evaluate manufacturers against the FDA's premarket cybersecurity guidance before procurement. Request SBOMs, vulnerability disclosure policies, historical CVE disclosure records, and patching commitments in writing as part of the purchasing process. A vendor unwilling to provide this documentation during sales discussions is unlikely to be a reliable security partner after deployment.
Business Associate Agreements (BAAs) are required under HIPAA for any vendor with access to ePHI. This includes vendors who receive device telemetry containing patient identifiers, even if their primary service is technical maintenance rather than data handling. If a vendor resists signing a BAA, treat that as a procurement red flag, not a negotiating point.
Just-in-time access provisioning replaces persistent vendor VPN credentials with time-limited, session-specific access that requires approval, is scoped to only the devices being serviced, and generates a full audit log. Persistent credentials that are rarely used still represent active attack surface. Vendor accounts with standing access are among the most common targets in supply chain intrusion campaigns.
For organizations evaluating zero trust architectures as an extension of these controls, our analysis of zero trust and secure data movement covers how that model applies to constrained devices that cannot run standard endpoint agents. Our guide to EDR, MDR, and XDR explains what to look for when evaluating monitoring providers for a healthcare environment.
Get a Medical Device Risk Assessment
Bellator Cyber Guard's healthcare security team evaluates your connected device inventory, identifies high-risk gaps, and delivers a prioritized remediation roadmap aligned with FDA and HIPAA requirements.
Incident Response When a Medical Device Is Compromised
When a medical device is compromised, or suspected to be compromised, the response process differs from a standard IT incident in ways that matter clinically. Patient safety takes priority over speed of containment. Decisions about isolating or shutting down a device must involve clinical leadership, not just IT security.
The first decision point is containment without clinical disruption. Isolating a network segment hosting infusion pumps requires coordination with nursing staff and pharmacy to confirm patients are not immediately affected. Device-specific playbooks should define who has clinical authority to approve isolation, what the manual or alternate-device workaround is, and how long that workaround can be safely maintained before clinical risk exceeds acceptable limits.
HIPAA breach notification obligations require covered entities to notify affected individuals within 60 days of discovering a breach involving ePHI. If the device incident involves ePHI, which applies to most networked clinical devices, the notification clock starts at discovery, not at containment. Careful timeline documentation from the moment of initial detection is essential for both regulatory compliance and any subsequent OCR investigation. The 60-day window is firm. Organizations that cannot demonstrate when discovery occurred face an unfavorable presumption in enforcement proceedings.
After an incident, conduct a root cause analysis that addresses how the device was initially accessed, how long it was compromised before detection, and which control gaps allowed the incident to reach that point. Feed those findings directly into your risk assessment and use them to drive prioritization in your security roadmap. This continuous improvement cycle is the operational core of a mature medical device cybersecurity program. Our HIPAA compliance checklist for small practices provides a structured framework for maintaining this documentation across your entire environment.
Schedule Your Medical Device Security Assessment
Our healthcare security experts will evaluate your connected device inventory, identify gaps aligned with FDA and HIPAA requirements, and deliver a prioritized remediation roadmap for your practice.
Frequently Asked Questions
Medical device cybersecurity is the ongoing process of monitoring, identifying, and addressing vulnerabilities in networked clinical devices throughout their operational lifecycle. It covers devices that store, process, or transmit patient data and includes both the technical controls applied by healthcare organizations and the security measures required of device manufacturers by the FDA.
Two primary frameworks apply. The FDA governs manufacturers of connected "cyber devices" under Section 524B of the Federal Food, Drug, and Cosmetic Act, requiring SBOMs, vulnerability disclosure policies, and postmarket patch commitments. HIPAA's Security Rule (45 CFR Part 164) governs covered entities and requires administrative, physical, and technical safeguards for any device that stores, processes, or transmits electronic protected health information (ePHI).
An SBOM is a structured inventory of all software components, including open-source libraries and third-party code, embedded in a medical device. The FDA now requires manufacturers to include SBOMs in premarket submissions for connected devices. For healthcare organizations, SBOMs make it possible to identify which devices are affected when a new vulnerability is disclosed in a specific software component, enabling faster and more targeted response.
Compensating controls can reduce risk when patching is not possible. These include network segmentation that isolates the device from other systems, application-layer firewalls that restrict the device to only required communication paths, enhanced monitoring for anomalous behavior, and physical access controls that limit who can interact with the device. Document these compensating controls in your annual HIPAA security risk assessment so they are available during any OCR review.
Under Section 524B of the FD&C Act, manufacturers must monitor postmarket cybersecurity risks, deploy patches within a reasonably justified timeframe, and maintain a coordinated vulnerability disclosure policy. The FDA also issues safety communications when specific device vulnerabilities are identified. Healthcare organizations can review a vendor's historical CVE disclosure records and FDA safety communication history before making purchasing decisions.
Ransomware typically reaches medical devices through lateral movement after an attacker gains initial access via a phishing email, an unpatched perimeter device, or compromised vendor credentials. Once inside the network, attackers pivot from workstations to networked medical equipment, targeting devices that are harder to restore quickly because they create maximum operational pressure. Network segmentation that isolates medical devices from corporate workstations is the primary control against this attack path.
Yes. The HIPAA Security Rule requires covered entities to conduct a thorough risk assessment that identifies all systems containing ePHI, including networked medical devices. HHS Office for Civil Rights enforcement actions have cited inadequate risk assessment coverage of medical devices as a finding in penalty proceedings. Your annual risk assessment should include a current device inventory with OS versions, firmware versions, and identified vulnerabilities.
Evaluate the manufacturer's Security Development Lifecycle (SDL) practices, request the SBOM for the device, review their coordinated vulnerability disclosure policy and historical CVE records, confirm their patch delivery commitments and timelines, and verify that their remote access practices are compatible with just-in-time access provisioning. Require that any vendor with access to ePHI signs a Business Associate Agreement before deployment.
Review your medical device inventory and risk assessment at minimum annually. Conduct firewall rule audits quarterly. Perform penetration testing of segmented medical device network zones at least once per year, or after any significant network change. Update device-specific incident response playbooks whenever a new device category is added or a significant vulnerability is discovered. After any incident, update the program before the 60-day HIPAA breach notification window closes.
The Internet of Medical Things refers specifically to networked devices used in clinical settings, including patient monitors, infusion pumps, imaging systems, implantable devices, and diagnostic analyzers. Unlike consumer or industrial IoT devices, IoMT devices are subject to FDA oversight, must meet HIPAA requirements when they handle patient data, and carry direct patient safety implications if compromised. The regulatory and clinical stakes of IoMT security are substantially higher than for general-purpose IoT.
From requirement to defensible practice
Turn HIPAA requirements into safeguards that fit patient care
A useful compliance path makes the obligation clear, identifies the evidence to retain, and connects written policy to the safeguards used every day.
People also look for
Keep exploring HIPAA security
Connect HIPAA requirements to the safeguards, assessments, and everyday decisions a healthcare practice can actually implement.
- Common question: HIPAA cybersecurity requirementsUse the plain-language HIPAA guideUnderstand administrative, physical, and technical safeguards without sorting through legal language.
- Common question: HIPAA security risk assessmentPrepare for a HIPAA risk assessmentIdentify vulnerabilities, document risk, and prioritize the gaps that matter most.
- Common question: HIPAA Security Rule explainedReview the HIPAA Security RuleSee how the standards and implementation specifications fit together.
- Common question: healthcare ransomware protectionReduce healthcare ransomware riskProtect patient data and keep clinical operations recoverable after an attack.
- Common question: HIPAA endpoint securityProtect practice workstations and devicesApply managed endpoint detection to the devices that access protected health information.



